BlackRock
EDVA

BlackRock’s Endovia Health Sciences, Inc. EDVA Stock Holding History

BlackRock’s Portfolio EDVA Stock Details EDVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-13
Closed -$37 – 5786
2025
Q4 		$37 Hold
13
– – ﹤0.01% 5497
2025
Q3 		$125 Hold
13
– – ﹤0.01% 5399
2025
Q2 		$199 Hold
13
– – ﹤0.01% 5402
2025
Q1 		$74 Hold
13
– – ﹤0.01% 5384
2024
Q4 		$340 Hold
13
– – ﹤0.01% 5334
2024
Q3 		$532 Sell
13
-117
-90% -$5.89K ﹤0.01% 5157
2024
Q2 		$4.79K Sell
130
-387
-75% -$18.1K ﹤0.01% 5129
2024
Q1 		$38.1K Sell
517
-12
-2% -$956 ﹤0.01% 4926
2023
Q4 		$46.8K Sell
529
-6
-1% -$571 ﹤0.01% 4977
2023
Q3 		$50.5K Sell
535
-22
-4% -$2.85K ﹤0.01% 5001
2023
Q2 		$99.8K Buy
557
+87
+19% +$15.9K ﹤0.01% 4910
2023
Q1 		$123K Buy
470
+80
+21% +$15.9K ﹤0.01% 4910
2022
Q4 		$60K Buy
390
+8
+2% +$1.4K ﹤0.01% 5185
2022
Q3 		$84K Sell
382
-26
-6% -$9.87K ﹤0.01% 5226
2022
Q2 		$195K Buy
+408
New +$147K ﹤0.01% 5037

Other funds holding EDVA

HF
HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return
VF
Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return
STA
Summit Trail Advisors New York $7.95B AUM 26.49% 1-Year Est. Return
PM
Phraction Management Colchester, Connecticut $596M AUM 36.77% 1-Year Est. Return
LWM
Lifetime Wealth Management Rockwall, Texas $171M AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
CL
Choreo LLC Rockford, Illinois $9.11B AUM 26.3% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

BlackRock's EDVA Position: Q1 2026 in Review

BlackRock sold out of Endovia Health Sciences, Inc. (EDVA) in Q1 2026, closing a stake of 13 shares — an estimated $37 sold.

BlackRock first reported a position in EDVA in Q2 2022 and held it in 15 quarters. The position peaked at $195K in Q2 2022. 15 funds tracked by Wall St. Rank hold EDVA as of Q1 2026.

  • BlackRock reported no remaining Endovia Health Sciences, Inc. position as of Q1 2026 after selling out during the quarter.
  • BlackRock sold 13 Endovia Health Sciences, Inc. shares in Q1 2026, an estimated $37.
  • BlackRock first reported a position in Endovia Health Sciences, Inc. in Q2 2022 and held it in 15 quarters.
  • BlackRock's Endovia Health Sciences, Inc. position peaked at $195K in Q2 2022.
  • 15 funds tracked by Wall St. Rank held Endovia Health Sciences, Inc. as of Q1 2026.

Based on BlackRock's 13F filing for Q1 2026, filed 13 May 2026.